We hereby consent to the
incorporation by reference in the Registration Statements on Form S-3
(File Nos. 33-61853, 333-51790, 333-31548, 333-63802,
333-100727, 333-109179) and in the Registration Statements on Form S-8
(File Nos. 33-58359, 33-60437, 333-10003, 333-33249, 333-83677,
333-51906, 33-30007, 33-68208, 333-33265, 333-10005,
333-33251, 333-83669, 333-33291, 33-21241, 333-55126,
333-42371, 333-81275, 333-87967, 333-81277, 333-83673,
333-64103, 333-83681, 333-51872, 333-52202, 333-66130,
333-70310, 333-76762, 333-76766, 333-76768, 333-76770,
333-100722, 333-90514, 333-90512, 333-90510, 333-64095,
333-106691, 333-106692, 333-111314, 333-116650, 333-116651,
333-116653, 333-114184, 333-125723, 333-125724, 333-125726)
of Genzyme Corporation of our report dated March 1, 2007 relating to the
consolidated financial statements, managements assessment of the effectiveness
of internal control over financial reporting and the effectiveness of internal
control over financial reporting, which appears in the Annual Report to
Shareholders, which is incorporated in this Annual Report on Form 10-K.
We also consent to the incorporation by reference of our report dated March 1,
2007 relating to Genzyme Corporations financial statement schedule, which
appears in this Form 10-K and of our report dated February 27,
2007 relating to the financial statements of BioMarin/Genzyme LLC which appears
in this Form 10-K.
/s/ PricewaterhouseCoopers LLP
Boston, Massachusetts
March 1, 2007
Bet you've never seen portfolio analytics like these.